Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
Diseases » Adrenoleukodystrophy » Prevalence
 

Prevalence and Incidence of Adrenoleukodystrophy

Prevalance of Adrenoleukodystrophy:

1 per 20,000 people suffer from X-linked adrenoleukodystrophy, Genetics Home reference website ... see also overview of Adrenoleukodystrophy.

Prevalance Rate:

approx 1 in 20,000 or 0.00% or 13,600 people in USA [Source statistic for calcuation: "1 per 20,000 people suffer from X-linked adrenoleukodystrophy, Genetics Home reference website" -- see also general information about data sources]

Adrenoleukodystrophy: Rare Disease

Adrenoleukodystrophy is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH). This means that Adrenoleukodystrophy, or a subtype of Adrenoleukodystrophy, affects less than 200,000 people in the US population.

About prevalence and incidence statistics:

The term 'prevalence' of Adrenoleukodystrophy usually refers to the estimated population of people who are managing Adrenoleukodystrophy at any given time. The term 'incidence' of Adrenoleukodystrophy refers to the annual diagnosis rate, or the number of new cases of Adrenoleukodystrophy diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.

 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise